Evaluation of the Effectiveness of Extending the "Passerelle" System for Prescribing Adapted Physical Activity to Patients With Type 2 Diabetes in Nouvelle-AQUItaine (France)
Starting soon · Not applicable
Conditions studied: Diabetes Mellitus, Type 2
In brief
Type 2 diabetes is on the increase worldwide. Two major risk factors have been identified: overweight and physical inactivity. National and international recommendations encourage general practitioner to guide patients in changing their lifestyle. As regards physical activity in France, general practitioner have been able to prescribe adapted physical activity (APA) for their patients since 2016. In type 2 diabetes, it is known that physical activity interventions are cost-effective. However, these interventions are often too expensive and far removed from real life. It is also known that the benefits of intervention increase up to 18 months, then diminish to zero at 36 months. In Nouvelle-Aquitaine, France, the "PEPS Sport-santé network", offers physical activity coaching for patients who are not sufficiently active: the "Passerelle" program. Patients can benefit from a weekly physical activity session for 6 months. The investigators would therefore like to assess whether extending the existing "Passerelle program" by 6 months, with one session every 15 days, is effective in maintaining the volume of physical activity 12 months after the end of the intervention.
Key facts
- Study ID
- NCT06493955
- Run by
- University Hospital, Bordeaux
- People needed
- 308
- Starts
- 2026-09-01
- Expected to finish
- 2029-09-01
- Last updated by the study team
- 2026-08-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with type 2 diabetes with initial diagnosis of fasting blood glucose > 1.26 g/l on 2 occasions
- Patient aged 18 or over
- Patient with a Marshall score ≤ 3
- Patient residing in the Nouvelle-Aquitaine region
- Patient eligible for the "Passerelle" program
- Patient willing to participate
- Patient agreeing to take part in the study and having signed an informed consent form
- Person affiliated or benefiting from a social security scheme.
You may not qualify if…
- Patient with any other unstabilized pathology:
- Cardiovascular: unstable angina, stress angina, malignant hypertension, recent myocardial infarction, unstabilized heart disease
- Pulmonary: uncontrolled asthma, COPD exacerbation
- Endocrine: diabetes with HbA1c > 9%, plantar perforator disease
- Pregnant patient
- Diabetic patient with contraindication to APA prescription
- Patient under court protection
Where it is running
- Cabinet Médical Bergerac — Bergerac, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.